2026年1月1日生效 接替Luigi La Corte的 Mike McClellan CFO Recordati names Mike McClellan CFO effective Jan. 1, 2026, succeeding Luigi La Corte.

Recordati 已任命 Mike McClellan 为新任首席财务官，自 2026 年 1 月 1 日起生效，接替将于 2025 年底卸任但仍留在董事会的 Luigi La Corte。 Recordati has appointed Mike McClellan as its new Chief Financial Officer, effective January 1, 2026, succeeding Luigi La Corte, who will step down at the end of 2025 but remain on the board. McClellan是拥有近30年制药业经验的美国人,曾在Almirall担任首席财务官,在Teva和Sanofi担任多个地区的高级财务职务。 McClellan, an American with nearly 30 years of pharmaceutical industry experience, previously served as CFO at Almirall and held senior finance roles at Teva and Sanofi across multiple regions. 总部设在米兰的公司报告说,在2025年上半年金融业绩强劲,收入增长11.7%,EBITDA公司增长增长,并继续将重点放在150个国家的专科、初级保健和罕见疾病治疗上。 The company, headquartered in Milan, reported strong financial performance in the first half of 2025, with revenue up 11.7% and EBITDA growth, and continues to focus on specialty, primary care, and rare disease treatments across 150 countries.